ABI3BP’s activity is not limited to lung cancer; it has also demonstrated tumor-suppressive functions in other malignancies, such as esophageal and breast cancers, where it downregulates oncogenic signals, making it a versatile tumor suppressor across different cancer types [10,11]. The gene discussed is ABI3BP; the disease is neoplasm.